Bevacizumab and cetuximab with conventional chemotherapy reduced pancreatic tumor weight in mouse pancreatic cancer xenografts. [electronic resource]
Producer: 20180110Description: 141-150 p. digitalISSN:- 1591-9528
- Animals
- Antineoplastic Agents, Immunological -- administration & dosage
- Bevacizumab -- administration & dosage
- Cetuximab -- administration & dosage
- Disease Models, Animal
- Drug Therapy -- methods
- Drug Therapy, Combination -- methods
- Female
- Heterografts
- Humans
- Mice, Inbred BALB C
- Pancreatic Neoplasms -- drug therapy
- Treatment Outcome
- Tumor Burden
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.